Toxys is global leading expert that develops and offers a broad spectrum of unique animal-free laboratory tests for the safety assessment of novel medicines, chemicals, cosmetics and food. We are experts in the fields of genotoxicity, developmental toxicology and mechanistic toxicity testing. We develop assays with the focus on understanding the mode-of-action of toxic compounds. Our ToxTracker® assay accurately identifies genotoxic compounds, ReproTracker® detects developmental toxicity and the ToxProfiler™ assay provides a broad toxicity profile of compounds. Our unique assays provide relevant information to avoid compounds failing at a late stage of development due to unforeseen toxicity.
We aim to bring information to our customers that is essential to make informed decisions on which compounds to progress in drug/compound development, thereby contributing to the development of better medicines and products and to reduce animal testing. Every novel chemical compound that is developed by pharmaceutical, chemical, cosmetics or food companies has to be rigorously tested for human health hazards before being considered safe for marketing. Current in vitro toxicity tests, which are an essential part of compound risk assessment, often suffer from a low predictive value and lack the possibility to provide insight into the mode-of-action of toxic compounds. To address these unmet needs, Toxys offers a diverse portfolio of in vitro assays that provide mode-of-action information on toxic compounds and provide information relevant to human health.
The assays are used for early compound screening, follow-up testing and mode-of-action assessment, potency ranking and chemical read-across and are particularly useful in weight-of-evidence (WoE) and adverse outcome pathway (AOP) approaches for chemical safety assessment. Toxys is internationally recognised for its scientific expertise, high-quality results and responsiveness.
Company Details
- Employees
- 37
- Founded
- -
- Address
- De Limes 7, Oegstgeest,2342 Dh,netherlands
- Phone
- +31 71 3322470
- in****@****xys.com
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- toxys.com
- Keywords
- Genotoxicity testing, Mechanism-based toxicology, DNA damage response, Mammalian reporter assays, Stem cells, BAC technologies.
- HQ
- Oegstgeest
- Competitors
- Johns Hopkins Center for Alternatives to Animal Testing (CAAT), The 3Rs Collaborative (3RsC), Galapagos, Centre for Human Drug Research, ALTERTOX, Ncardia, Toxys Inc., National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), MIMETAS, BioPartner Leiden.
Toxys Questions
Toxys's helpline number is +31 71 3322470
Toxys's website is toxys.com
Toxys's LinkedIn profile is https://nl.linkedin.com/company/toxys
Toxys has
37 employees.
View email and phone details for 37
employees at Toxys.
Toxys's industry is
Research Services
Toxys's top competitors are
Johns Hopkins Center For Alternatives To Animal Testing (Caat),
The 3rs Collaborative (3rsc),
Galapagos,
Centre For Human Drug Research,
Altertox,
Ncardia,
Toxys Inc.,
National Centre For The Replacement, Refinement And Reduction Of Animals In Research (Nc3rs),
Mimetas,
Biopartner Leiden.
Toxys's support email address is info@toxys.com
Toxys's categories are Research Services
Toxys's founding year is 2014
